Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Philip Stella"'
Autor:
Edward S. Kim, Vamsidhar Velcheti, Tarek Mekhail, Cindy Yun, Sarah M. Shagan, Sylvia Hu, Young Kwang Chae, Ticiana A. Leal, Jonathan E. Dowell, Michaela L. Tsai, Christopher S. R. Dakhil, Philip Stella, Yanling Jin, David S. Shames, Erica Schleifman, David A. Fabrizio, See Phan, Mark A. Socinski
Publikováno v:
Nature Medicine. 28:939-945
Tumor mutational burden (TMB) in circulating tumor DNA (ctDNA) has shown promise in predicting benefit from PD-L1/PD-1 inhibitors in retrospective studies. Aiming to assess blood TMB (bTMB) prospectively, we conducted B-F1RST (NCT02848651), an open-l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6af5f44d27b1e8f0cd1b472e336e4278
https://doi.org/10.1038/s41591-022-01754-x
https://doi.org/10.1038/s41591-022-01754-x
Autor:
Edward S, Kim, Vamsidhar, Velcheti, Tarek, Mekhail, Cindy, Yun, Sarah M, Shagan, Sylvia, Hu, Young Kwang, Chae, Ticiana A, Leal, Jonathan E, Dowell, Michaela L, Tsai, Christopher S R, Dakhil, Philip, Stella, Yanling, Jin, David S, Shames, Erica, Schleifman, David A, Fabrizio, See, Phan, Mark A, Socinski
Publikováno v:
Nature medicine. 28(5)
Tumor mutational burden (TMB) in circulating tumor DNA (ctDNA) has shown promise in predicting benefit from PD-L1/PD-1 inhibitors in retrospective studies. Aiming to assess blood TMB (bTMB) prospectively, we conducted B-F1RST ( NCT02848651 ), an open
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f2fe4e86517c234842949cf16aa89c6d
https://pubmed.ncbi.nlm.nih.gov/35477773
https://pubmed.ncbi.nlm.nih.gov/35477773
Publikováno v:
Journal of oncology practice. 14(10)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0708f1336a1b9c4d5174e5abe620b16d
https://pubmed.ncbi.nlm.nih.gov/30207855
https://pubmed.ncbi.nlm.nih.gov/30207855
Publikováno v:
Biomicrofluidics. 8(6)
Inertial microfluidics is an emerging class of technologies developed to separate circulating tumor cells (CTCs). However, defining design parameters and flow conditions for optimal operation remains nondeterministic due to incomplete understanding o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f559d286f9c1d4e38518d59ec4b8d750
https://pubmed.ncbi.nlm.nih.gov/25553193
https://pubmed.ncbi.nlm.nih.gov/25553193
Autor:
Shirin Khambata-Ford, Heinz-Josef Lenz, Philip Stella, Eric K. Rowinsky, Nozar Azarnia, Robert J. Mayer, Allen Lee Cohn, Eric Van Cutsem, David J. Mauro, Andrew William Pippas, B. Mirtsching, Zenta Tsuchihashi, Philip J. Gold
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 24(30)
Purpose This multicenter study evaluated the antitumor activity of cetuximab, an immunoglobulin G1 antibody directed at the epidermal growth factor receptor (EGFR), in metastatic colorectal carcinoma (CRC) refractory to irinotecan, oxaliplatin, and a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76d19055690bdd3116db315b3ddde693
https://pubmed.ncbi.nlm.nih.gov/17050875
https://pubmed.ncbi.nlm.nih.gov/17050875
Autor:
Aminah, Jatoi, Shauna, Hillman, Philip, Stella, Kendrith, Rowland, Roscoe, Morton, Shaker, Dakhil
Publikováno v:
The journal of supportive oncology. 4(7)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::185906fcf3ad9e54bbf92966fb4ce6e8
https://pubmed.ncbi.nlm.nih.gov/16892691
https://pubmed.ncbi.nlm.nih.gov/16892691